Fernando Velayos graduated medical school with honors from the University of California, San Francisco. He completed his residency training at UCSF where he served as Chief Resident and then remained for GI fellowship. He completed additional training in inflammatory bowel disease at Mayo Clinic and research training at University of California, Berkeley, where he was awarded a Masters in Public Health.
He is a member of the American College of Gastroenterology, American Gastroenterological Association, and the Crohn’s and Colitis Foundation of America. He currently serves as an associate editor for Digestive Diseases and Science and serves on the editorial board of several journals. His clinical and research interests involve use of novel therapies to treat IBD and prevention of colon cancer in patients with inflammatory bowel disease.
